Current
Research in
Ophthalmology >>

The following clinical trials in ophthalmology have completed enrollment:

Glaucoma

• Visual Function in African-American Eyes with Glaucoma or OHT

Retina

• A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS Applicator System) in the Treatment of Patients with Diabetic Macular Edema
• A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration- (CLEAR IT 3)
• A Phase 3, randomized, double-masked, parallel-assignment study of intravitreal bevasiranib sodium, administered every 8 or 12 weeks as maintenance therapy following three injections of Lucentis® compared with Lucentis® monotherapy every 4 weeks in patients with Exudative Age-Related Macular Degeneration (AMD) - ACU301B

Uveitis

• The Use of Confocal Microscopy to Characterise Keratic Precipitates (KPs) in Sarcoidosis- Associated Uveitis
• Quantification of the Effect of Free Radicals in Sera and Tear Films of Uveitic Patients

Home > Current Research > Clinical Trials in Ophthalmology > COMPLETED ENROLLMENT